ADHD & attention
Well-established with standard protocolsADHD is the most-studied use of neurofeedback, with controlled trials going back to 1976. For the standard protocols — theta/beta, sensorimotor rhythm and slow cortical potentials — meta-analyses report medium-to-large effects on inattention and impulsivity, with gains maintained or increased six to twelve months after training ends. A 2020 international review rated standard-protocol neurofeedback a well-established treatment with remission rates of 32–47%. A 2025 meta-analysis that pooled every kind of protocol found a significant benefit on blinded ratings only in the trials that used the standard protocols. Kerov plans use standard protocols, selected from each person’s qEEG brain map.
Pigott HE, Cannon R. (2014). Neurofeedback is the best available first-line treatment for ADHD: what is the evidence for this claim?. NeuroRegulation. Review of 16 controlled studies since 2000, 828 participants.
Across the 16 studies, neurofeedback improved parent-rated core symptoms in 15 and teacher-rated symptoms in 12, with gains maintained at six-month and two-year follow-ups; four studies reported outcomes equivalent to stimulant medication. The authors argue neurofeedback should be recognised as a first-line option.
Read the full paper (free) ↗Arns M, Clark CR, Trullinger M, deBeus R, Mack M, Aniftos M. (2020). Neurofeedback and attention-deficit/hyperactivity disorder (ADHD) in children: rating the evidence and proposed guidelines. Applied Psychophysiology and Biofeedback. Quantitative review of meta-analyses and four multicenter RCTs.
Standard neurofeedback protocols met a stricter version of the APA criteria for a well-established treatment: medium-to-large effect sizes, remission rates of 32–47%, effects sustained at 6–12 months, no evidence of publication bias and no neurofeedback-specific side effects.
Read the full paper (free) ↗Van Doren J, Arns M, Heinrich H, Vollebregt MA, Strehl U, Loo SK. (2019). Sustained effects of neurofeedback in ADHD: a systematic review and meta-analysis. European Child & Adolescent Psychiatry. 10 randomized trials with 2–12 month follow-up, 506 children.
Inattention improved with a medium effect at the end of training and a large effect at follow-up; hyperactivity/impulsivity improved with medium effects at both points. Non-active control conditions showed no lasting effect, and neurofeedback’s advantage over them was larger at follow-up than at the end of training.
Read the full paper (free) ↗Micoulaud-Franchi J-A, Geoffroy PA, Fond G, Lopez R, Bioulac S, Philip P. (2014). EEG neurofeedback treatments in children with ADHD: an updated meta-analysis of randomized controlled trials. Frontiers in Human Neuroscience. 5 RCTs with semi-active or sham controls, 263 children.
Parent ratings of overall symptoms, inattention and hyperactivity/impulsivity all improved significantly versus controls; on teacher ratings, inattention improved significantly.
Read the full paper (free) ↗Riesco-Matías P, Yela-Bernabé JR, Crego A, Sánchez-Zaballos E. (2021). What do meta-analyses have to say about the efficacy of neurofeedback applied to children with ADHD? Review of previous meta-analyses and a new meta-analysis. Journal of Attention Disorders. Review of 7 meta-analyses plus a new one of 17 RCTs.
Randomized trials support neurofeedback’s efficacy on parent ratings, and inattention improved on possibly blinded ratings as well; preliminary comparisons suggested stimulant medication produces larger short-term effects.
Read the paper ↗Arns M, de Ridder S, Strehl U, Breteler M, Coenen A. (2009). Efficacy of neurofeedback treatment in ADHD: the effects on inattention, impulsivity and hyperactivity: a meta-analysis. Clinical EEG and Neuroscience. 15 studies, 1,194 participants.
Large effect sizes for inattention and impulsivity and a medium effect for hyperactivity; under the AAPB/ISNR efficacy guidelines the authors rate neurofeedback for ADHD “Efficacious and Specific” (Level 5).
Read the paper ↗Westwood SJ, Aggensteiner P-M, Kaiser A, et al. (2025). Neurofeedback for attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. JAMA Psychiatry. 38 randomized trials, 2,472 participants aged 5–40.
Pooling all protocols, no significant improvement in blinded ratings of total ADHD symptoms; restricted to trials using established standard protocols, a small significant improvement, plus a small gain in processing speed. The authors recommend standard protocols and precision approaches to identify who benefits.
Read the paper ↗Roley-Roberts ME, Pan X, Bergman R, et al. (2022). For which children with ADHD is TBR neurofeedback effective? Comorbidity as a moderator. Applied Psychophysiology and Biofeedback. 142 children aged 7–10, double-blind RCT, 13-month follow-up.
Response to theta/beta neurofeedback varied with comorbidity: children whose ADHD came with anxiety responded better to the control condition, while children with oppositional behaviour responded better to neurofeedback at 13 months. The authors conclude the protocol should be matched to the child.
Read the paper ↗
More studies on this topic: ISNR bibliography ↗ · NeuroRegulation journal ↗
